cafs cell line Search Results


90
BioIVT Inc cafs cell lines
Cafs Cell Lines, supplied by BioIVT Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cafs cell lines/product/BioIVT Inc
Average 90 stars, based on 1 article reviews
cafs cell lines - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Vitro Biopharma Inc human squamous cell carcinoma fibroblasts caf1
Human Squamous Cell Carcinoma Fibroblasts Caf1, supplied by Vitro Biopharma Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human squamous cell carcinoma fibroblasts caf1/product/Vitro Biopharma Inc
Average 90 stars, based on 1 article reviews
human squamous cell carcinoma fibroblasts caf1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
SLIT2 LTD cafs cell line
Cafs Cell Line, supplied by SLIT2 LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cafs cell line/product/SLIT2 LTD
Average 90 stars, based on 1 article reviews
cafs cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Jackson Laboratory cafs cell line
Tumor cell-derived IL-1 has a key role in TSLP secretion by <t>CAFs.</t> a TSLP secretion by CAFs ( n = 18) either untreated (NT) or treated with the indicated cytokines (20 ng/ml). Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. b TSLP secretion by CAFs in the absence (NT) or in the presence of increasing doses of recombinant IL-1α, IL-1β and TNF-α. Significance was determined using Mann Whitney test. c TSLP secretion by CAFs ( n = 14) either untreated (NT) or treated with supernatants of necrotic IL-1 negative (IL-1-) ( n = 16) or positive (IL-1+) ( n = 26) tumor cells. Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. d TSLP secretion by CAFs induced by necrotic tumor cell-derived supernatants in the absence (NT) or in the presence of the indicated neutralizing Abs or isotype control Abs or the IL-1RA (Anakinra). Representative experiments performed with the indicated tumor cell lines. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. e Cumulative results: each dot refers to a single experiment and represents the percentage of inhibition calculated on the value of TSLP secretion in the presence of the isotype control antibody. f TSLP secretion by CAFs either untreated or stimulated with the supernatant of <t>necrotic</t> <t>Hs766T</t> cells after treatment with IL-1α/IL-1β siRNA or negative control siRNA. Treatment of CAFs with recombinant IL-1α + IL-1β (20 ng/ml each) in the absence or in the presence of anakinra were used as controls. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. Values significantly different were indicated as: * p < 0.05, ** p < 0.01 and *** p < 0.001
Cafs Cell Line, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cafs cell line/product/Jackson Laboratory
Average 90 stars, based on 1 article reviews
cafs cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
BioIVT Inc human primary ovarian cancer fibroblast cell line (cafs)
Tumor cell-derived IL-1 has a key role in TSLP secretion by <t>CAFs.</t> a TSLP secretion by CAFs ( n = 18) either untreated (NT) or treated with the indicated cytokines (20 ng/ml). Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. b TSLP secretion by CAFs in the absence (NT) or in the presence of increasing doses of recombinant IL-1α, IL-1β and TNF-α. Significance was determined using Mann Whitney test. c TSLP secretion by CAFs ( n = 14) either untreated (NT) or treated with supernatants of necrotic IL-1 negative (IL-1-) ( n = 16) or positive (IL-1+) ( n = 26) tumor cells. Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. d TSLP secretion by CAFs induced by necrotic tumor cell-derived supernatants in the absence (NT) or in the presence of the indicated neutralizing Abs or isotype control Abs or the IL-1RA (Anakinra). Representative experiments performed with the indicated tumor cell lines. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. e Cumulative results: each dot refers to a single experiment and represents the percentage of inhibition calculated on the value of TSLP secretion in the presence of the isotype control antibody. f TSLP secretion by CAFs either untreated or stimulated with the supernatant of <t>necrotic</t> <t>Hs766T</t> cells after treatment with IL-1α/IL-1β siRNA or negative control siRNA. Treatment of CAFs with recombinant IL-1α + IL-1β (20 ng/ml each) in the absence or in the presence of anakinra were used as controls. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. Values significantly different were indicated as: * p < 0.05, ** p < 0.01 and *** p < 0.001
Human Primary Ovarian Cancer Fibroblast Cell Line (Cafs), supplied by BioIVT Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human primary ovarian cancer fibroblast cell line (cafs)/product/BioIVT Inc
Average 90 stars, based on 1 article reviews
human primary ovarian cancer fibroblast cell line (cafs) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cellular Engineering Technologies Inc cafs cell line
Tumor cell-derived IL-1 has a key role in TSLP secretion by <t>CAFs.</t> a TSLP secretion by CAFs ( n = 18) either untreated (NT) or treated with the indicated cytokines (20 ng/ml). Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. b TSLP secretion by CAFs in the absence (NT) or in the presence of increasing doses of recombinant IL-1α, IL-1β and TNF-α. Significance was determined using Mann Whitney test. c TSLP secretion by CAFs ( n = 14) either untreated (NT) or treated with supernatants of necrotic IL-1 negative (IL-1-) ( n = 16) or positive (IL-1+) ( n = 26) tumor cells. Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. d TSLP secretion by CAFs induced by necrotic tumor cell-derived supernatants in the absence (NT) or in the presence of the indicated neutralizing Abs or isotype control Abs or the IL-1RA (Anakinra). Representative experiments performed with the indicated tumor cell lines. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. e Cumulative results: each dot refers to a single experiment and represents the percentage of inhibition calculated on the value of TSLP secretion in the presence of the isotype control antibody. f TSLP secretion by CAFs either untreated or stimulated with the supernatant of <t>necrotic</t> <t>Hs766T</t> cells after treatment with IL-1α/IL-1β siRNA or negative control siRNA. Treatment of CAFs with recombinant IL-1α + IL-1β (20 ng/ml each) in the absence or in the presence of anakinra were used as controls. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. Values significantly different were indicated as: * p < 0.05, ** p < 0.01 and *** p < 0.001
Cafs Cell Line, supplied by Cellular Engineering Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cafs cell line/product/Cellular Engineering Technologies Inc
Average 90 stars, based on 1 article reviews
cafs cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Broad Institute Inc cafs cell line
Tumor cell-derived IL-1 has a key role in TSLP secretion by <t>CAFs.</t> a TSLP secretion by CAFs ( n = 18) either untreated (NT) or treated with the indicated cytokines (20 ng/ml). Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. b TSLP secretion by CAFs in the absence (NT) or in the presence of increasing doses of recombinant IL-1α, IL-1β and TNF-α. Significance was determined using Mann Whitney test. c TSLP secretion by CAFs ( n = 14) either untreated (NT) or treated with supernatants of necrotic IL-1 negative (IL-1-) ( n = 16) or positive (IL-1+) ( n = 26) tumor cells. Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. d TSLP secretion by CAFs induced by necrotic tumor cell-derived supernatants in the absence (NT) or in the presence of the indicated neutralizing Abs or isotype control Abs or the IL-1RA (Anakinra). Representative experiments performed with the indicated tumor cell lines. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. e Cumulative results: each dot refers to a single experiment and represents the percentage of inhibition calculated on the value of TSLP secretion in the presence of the isotype control antibody. f TSLP secretion by CAFs either untreated or stimulated with the supernatant of <t>necrotic</t> <t>Hs766T</t> cells after treatment with IL-1α/IL-1β siRNA or negative control siRNA. Treatment of CAFs with recombinant IL-1α + IL-1β (20 ng/ml each) in the absence or in the presence of anakinra were used as controls. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. Values significantly different were indicated as: * p < 0.05, ** p < 0.01 and *** p < 0.001
Cafs Cell Line, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cafs cell line/product/Broad Institute Inc
Average 90 stars, based on 1 article reviews
cafs cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Bachem cafs cell line
Tumor cell-derived IL-1 has a key role in TSLP secretion by <t>CAFs.</t> a TSLP secretion by CAFs ( n = 18) either untreated (NT) or treated with the indicated cytokines (20 ng/ml). Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. b TSLP secretion by CAFs in the absence (NT) or in the presence of increasing doses of recombinant IL-1α, IL-1β and TNF-α. Significance was determined using Mann Whitney test. c TSLP secretion by CAFs ( n = 14) either untreated (NT) or treated with supernatants of necrotic IL-1 negative (IL-1-) ( n = 16) or positive (IL-1+) ( n = 26) tumor cells. Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. d TSLP secretion by CAFs induced by necrotic tumor cell-derived supernatants in the absence (NT) or in the presence of the indicated neutralizing Abs or isotype control Abs or the IL-1RA (Anakinra). Representative experiments performed with the indicated tumor cell lines. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. e Cumulative results: each dot refers to a single experiment and represents the percentage of inhibition calculated on the value of TSLP secretion in the presence of the isotype control antibody. f TSLP secretion by CAFs either untreated or stimulated with the supernatant of <t>necrotic</t> <t>Hs766T</t> cells after treatment with IL-1α/IL-1β siRNA or negative control siRNA. Treatment of CAFs with recombinant IL-1α + IL-1β (20 ng/ml each) in the absence or in the presence of anakinra were used as controls. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. Values significantly different were indicated as: * p < 0.05, ** p < 0.01 and *** p < 0.001
Cafs Cell Line, supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cafs cell line/product/Bachem
Average 90 stars, based on 1 article reviews
cafs cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Neuromics cafs cell line
Tumor cell-derived IL-1 has a key role in TSLP secretion by <t>CAFs.</t> a TSLP secretion by CAFs ( n = 18) either untreated (NT) or treated with the indicated cytokines (20 ng/ml). Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. b TSLP secretion by CAFs in the absence (NT) or in the presence of increasing doses of recombinant IL-1α, IL-1β and TNF-α. Significance was determined using Mann Whitney test. c TSLP secretion by CAFs ( n = 14) either untreated (NT) or treated with supernatants of necrotic IL-1 negative (IL-1-) ( n = 16) or positive (IL-1+) ( n = 26) tumor cells. Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. d TSLP secretion by CAFs induced by necrotic tumor cell-derived supernatants in the absence (NT) or in the presence of the indicated neutralizing Abs or isotype control Abs or the IL-1RA (Anakinra). Representative experiments performed with the indicated tumor cell lines. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. e Cumulative results: each dot refers to a single experiment and represents the percentage of inhibition calculated on the value of TSLP secretion in the presence of the isotype control antibody. f TSLP secretion by CAFs either untreated or stimulated with the supernatant of <t>necrotic</t> <t>Hs766T</t> cells after treatment with IL-1α/IL-1β siRNA or negative control siRNA. Treatment of CAFs with recombinant IL-1α + IL-1β (20 ng/ml each) in the absence or in the presence of anakinra were used as controls. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. Values significantly different were indicated as: * p < 0.05, ** p < 0.01 and *** p < 0.001
Cafs Cell Line, supplied by Neuromics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cafs cell line/product/Neuromics
Average 90 stars, based on 1 article reviews
cafs cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
SAS institute cafs cell line
Tumor cell-derived IL-1 has a key role in TSLP secretion by <t>CAFs.</t> a TSLP secretion by CAFs ( n = 18) either untreated (NT) or treated with the indicated cytokines (20 ng/ml). Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. b TSLP secretion by CAFs in the absence (NT) or in the presence of increasing doses of recombinant IL-1α, IL-1β and TNF-α. Significance was determined using Mann Whitney test. c TSLP secretion by CAFs ( n = 14) either untreated (NT) or treated with supernatants of necrotic IL-1 negative (IL-1-) ( n = 16) or positive (IL-1+) ( n = 26) tumor cells. Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. d TSLP secretion by CAFs induced by necrotic tumor cell-derived supernatants in the absence (NT) or in the presence of the indicated neutralizing Abs or isotype control Abs or the IL-1RA (Anakinra). Representative experiments performed with the indicated tumor cell lines. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. e Cumulative results: each dot refers to a single experiment and represents the percentage of inhibition calculated on the value of TSLP secretion in the presence of the isotype control antibody. f TSLP secretion by CAFs either untreated or stimulated with the supernatant of <t>necrotic</t> <t>Hs766T</t> cells after treatment with IL-1α/IL-1β siRNA or negative control siRNA. Treatment of CAFs with recombinant IL-1α + IL-1β (20 ng/ml each) in the absence or in the presence of anakinra were used as controls. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. Values significantly different were indicated as: * p < 0.05, ** p < 0.01 and *** p < 0.001
Cafs Cell Line, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cafs cell line/product/SAS institute
Average 90 stars, based on 1 article reviews
cafs cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
AstraZeneca ltd cafs cell line
Tumor cell-derived IL-1 has a key role in TSLP secretion by <t>CAFs.</t> a TSLP secretion by CAFs ( n = 18) either untreated (NT) or treated with the indicated cytokines (20 ng/ml). Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. b TSLP secretion by CAFs in the absence (NT) or in the presence of increasing doses of recombinant IL-1α, IL-1β and TNF-α. Significance was determined using Mann Whitney test. c TSLP secretion by CAFs ( n = 14) either untreated (NT) or treated with supernatants of necrotic IL-1 negative (IL-1-) ( n = 16) or positive (IL-1+) ( n = 26) tumor cells. Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. d TSLP secretion by CAFs induced by necrotic tumor cell-derived supernatants in the absence (NT) or in the presence of the indicated neutralizing Abs or isotype control Abs or the IL-1RA (Anakinra). Representative experiments performed with the indicated tumor cell lines. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. e Cumulative results: each dot refers to a single experiment and represents the percentage of inhibition calculated on the value of TSLP secretion in the presence of the isotype control antibody. f TSLP secretion by CAFs either untreated or stimulated with the supernatant of <t>necrotic</t> <t>Hs766T</t> cells after treatment with IL-1α/IL-1β siRNA or negative control siRNA. Treatment of CAFs with recombinant IL-1α + IL-1β (20 ng/ml each) in the absence or in the presence of anakinra were used as controls. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. Values significantly different were indicated as: * p < 0.05, ** p < 0.01 and *** p < 0.001
Cafs Cell Line, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cafs cell line/product/AstraZeneca ltd
Average 90 stars, based on 1 article reviews
cafs cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Tumor cell-derived IL-1 has a key role in TSLP secretion by CAFs. a TSLP secretion by CAFs ( n = 18) either untreated (NT) or treated with the indicated cytokines (20 ng/ml). Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. b TSLP secretion by CAFs in the absence (NT) or in the presence of increasing doses of recombinant IL-1α, IL-1β and TNF-α. Significance was determined using Mann Whitney test. c TSLP secretion by CAFs ( n = 14) either untreated (NT) or treated with supernatants of necrotic IL-1 negative (IL-1-) ( n = 16) or positive (IL-1+) ( n = 26) tumor cells. Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. d TSLP secretion by CAFs induced by necrotic tumor cell-derived supernatants in the absence (NT) or in the presence of the indicated neutralizing Abs or isotype control Abs or the IL-1RA (Anakinra). Representative experiments performed with the indicated tumor cell lines. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. e Cumulative results: each dot refers to a single experiment and represents the percentage of inhibition calculated on the value of TSLP secretion in the presence of the isotype control antibody. f TSLP secretion by CAFs either untreated or stimulated with the supernatant of necrotic Hs766T cells after treatment with IL-1α/IL-1β siRNA or negative control siRNA. Treatment of CAFs with recombinant IL-1α + IL-1β (20 ng/ml each) in the absence or in the presence of anakinra were used as controls. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. Values significantly different were indicated as: * p < 0.05, ** p < 0.01 and *** p < 0.001

Journal: Journal for Immunotherapy of Cancer

Article Title: The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer

doi: 10.1186/s40425-019-0521-4

Figure Lengend Snippet: Tumor cell-derived IL-1 has a key role in TSLP secretion by CAFs. a TSLP secretion by CAFs ( n = 18) either untreated (NT) or treated with the indicated cytokines (20 ng/ml). Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. b TSLP secretion by CAFs in the absence (NT) or in the presence of increasing doses of recombinant IL-1α, IL-1β and TNF-α. Significance was determined using Mann Whitney test. c TSLP secretion by CAFs ( n = 14) either untreated (NT) or treated with supernatants of necrotic IL-1 negative (IL-1-) ( n = 16) or positive (IL-1+) ( n = 26) tumor cells. Each symbol refers to a single experiment and represents the mean of duplicate determinations. Significance was determined using Mann Whitney test. d TSLP secretion by CAFs induced by necrotic tumor cell-derived supernatants in the absence (NT) or in the presence of the indicated neutralizing Abs or isotype control Abs or the IL-1RA (Anakinra). Representative experiments performed with the indicated tumor cell lines. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. e Cumulative results: each dot refers to a single experiment and represents the percentage of inhibition calculated on the value of TSLP secretion in the presence of the isotype control antibody. f TSLP secretion by CAFs either untreated or stimulated with the supernatant of necrotic Hs766T cells after treatment with IL-1α/IL-1β siRNA or negative control siRNA. Treatment of CAFs with recombinant IL-1α + IL-1β (20 ng/ml each) in the absence or in the presence of anakinra were used as controls. Error bars represent standard deviations of triplicate values. Significance was determined using Student’s t -test. Values significantly different were indicated as: * p < 0.05, ** p < 0.01 and *** p < 0.001

Article Snippet: 2 × 10 6 Hs766T (IL-1 positive) cells or 2 × 10 6 CAFs or 2 × 10 6 Hs766T cells plus 2 × 10 6 CAFs were injected in the pancreas of immunodeficient NSG mice (The Jackson Laboratory).

Techniques: Derivative Assay, MANN-WHITNEY, Recombinant, Control, Inhibition, Negative Control

Treatment of immunodeficient NSG mice orthotopically transplanted with IL-1 positive Hs766T cells plus CAFs with anakinra reduces TSLP expression in vivo. a Treatment schedule. Mice were orthotopically injected on day 0 with Hs766T cells plus CAFs. Hs766T cells alone and CAFs alone were injected as controls. The next day mice transplanted with Hs766T cells plus CAFs started intraperitoneal injection with the two indicated doses of anakinra and mice were sacrificed on day 6 after daily administration. b Hematoxylin and eosin staining of the pancreas. Left, a tumor mass (T) localized within the normal pancreas (N) is evident. Right, at higher magnification, histological features of pancreatic cancer with cancer cells, fibroblasts and extracellular matrix can be recognized. c Human (left) and mouse (right) TSLP mRNA expression in pancreata of NSG mice implanted with CAFs alone ( n = 3), Hs766T cells alone ( n = 3) or CAFs plus Hs766T cells ( n = 3). Significance was determined using Student’s t -test. d TSLP expression in pancreata of NSG mice untreated (NT) ( n = 4) or treated with the two indicated doses of Anakinra ( n = 4 for each dose). Significance was determined using Student’s t -test. Values significantly different were indicated as: * p < 0.05

Journal: Journal for Immunotherapy of Cancer

Article Title: The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer

doi: 10.1186/s40425-019-0521-4

Figure Lengend Snippet: Treatment of immunodeficient NSG mice orthotopically transplanted with IL-1 positive Hs766T cells plus CAFs with anakinra reduces TSLP expression in vivo. a Treatment schedule. Mice were orthotopically injected on day 0 with Hs766T cells plus CAFs. Hs766T cells alone and CAFs alone were injected as controls. The next day mice transplanted with Hs766T cells plus CAFs started intraperitoneal injection with the two indicated doses of anakinra and mice were sacrificed on day 6 after daily administration. b Hematoxylin and eosin staining of the pancreas. Left, a tumor mass (T) localized within the normal pancreas (N) is evident. Right, at higher magnification, histological features of pancreatic cancer with cancer cells, fibroblasts and extracellular matrix can be recognized. c Human (left) and mouse (right) TSLP mRNA expression in pancreata of NSG mice implanted with CAFs alone ( n = 3), Hs766T cells alone ( n = 3) or CAFs plus Hs766T cells ( n = 3). Significance was determined using Student’s t -test. d TSLP expression in pancreata of NSG mice untreated (NT) ( n = 4) or treated with the two indicated doses of Anakinra ( n = 4 for each dose). Significance was determined using Student’s t -test. Values significantly different were indicated as: * p < 0.05

Article Snippet: 2 × 10 6 Hs766T (IL-1 positive) cells or 2 × 10 6 CAFs or 2 × 10 6 Hs766T cells plus 2 × 10 6 CAFs were injected in the pancreas of immunodeficient NSG mice (The Jackson Laboratory).

Techniques: Expressing, In Vivo, Injection, Staining